What Happens If You Stay on 2.5mg Mounjaro? (October 2026)

01 · The short answer

What actually happens if you stay on 2.5mg

Staying on 2.5mg means you continue on the dose every patient starts on, and it was chosen for tolerability rather than results. Everyone starts Mounjaro on 2.5mg once a week. This starting dose is about letting your body adjust, not about weight loss itself.¹

In practice, there are three common outcomes. Some people notice a gentle appetite change and a little early loss, then find progress flattens. Others feel very little change at all. A small number feel well controlled on a low dose and their prescriber agrees to hold it for a while. None of these is unusual, but only the last is a planned decision made with clinical oversight.

The licence describes a stepwise ladder. After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹¹¹ Notice the wording: the dose can increase, depending on response and tolerance. Moving up is a decision, not an automatic timetable, and it is yours and your prescriber's to make together.

02 · Your decision

Is staying on 2.5mg right for you?

It can be reasonable for a short period if side effects are troubling you, but it is rarely a sensible long-term plan on its own. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.¹ If you are happy with how you feel but are not seeing results, that is a sign to talk about the next step rather than wait.

Ask yourself a few practical questions. Are side effects genuinely limiting you, or are you nervous about increasing? Has your appetite changed at all? Are you still following a reduced-calorie diet and being active, which the treatment is designed to work alongside? Your honest answers help your prescriber decide whether to hold, step up or discuss other options.

Higher is not automatically better either. Many people settle at a maintenance dose of 5mg, 10mg or 15mg, and your prescriber will guide the right pace.¹ The aim is the lowest dose that works for you, not the highest one you can reach.

03 · What to do next

What to do next

If you are on 2.5mg and unsure, the simplest step is a review. Our prescribing team carries out ongoing monthly reviews, dose-titration and follow-up assessments, and repeat orders re-check suitability, so you are never left guessing. If you are new to treatment, you can start with a free consultation on the Mounjaro pen page, where current pricing is shown. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99). For the wider picture, see our weight loss clinic guidance.

Whatever you decide, keep injecting on the same day each week and do not change doses on your own. Report anything unexpected to your prescriber, and you can report suspected side effects through the Yellow Card scheme.¹⁹

Related guide: Can You Stay on 2.5mg Mounjaro? In Stock UK.

04 · Why 2.5mg exists

Why 2.5mg is the starter dose

The 2.5mg strength exists so your body can adjust to the medicine before the dose rises. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly, and in the UK it is licensed for weight management in adults and for type 2 diabetes.¹ It comes as a pre-filled multi-dose pen, the KwikPen, in 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg strengths.

Understanding the mechanism helps explain the starter dose. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

Because the medicine slows stomach emptying and changes appetite signals, starting too high would be uncomfortable for many people. A low first dose lets your gut and appetite systems get used to the effect gradually. That is why the licensed ladder begins at 2.5mg for tolerability rather than because that strength is expected to deliver the full outcome.¹

This distinction matters for anyone considering staying put. The dose is a means to an end: it prepares the ground. Treating it as a destination is a bit like leaving a car in first gear because the engine sounds quieter there. You can do it, but you will not travel far, and the engine is not doing what it was built to do.

It also explains why people feel so differently on this dose. Some notice a clear change in hunger within days, while others feel almost nothing. Neither response predicts how you will do at higher strengths, because the starter dose was never meant to be the test of whether the medicine works for you.

Each KwikPen contains four weekly doses, so a pen of 2.5mg lasts four injections. If you remain on the starter strength, you simply keep using pens of that strength, but the pen itself does not change what the dose is designed to do. Your prescriber can explain how the step to the next strength would work in your case, and what to look for before moving up.

It may help to think of the starter dose as a trial period for your tolerability, not for the medicine's potential. If you tolerated it well, that is useful information: it suggests the next step is likely to be manageable. If you struggled, that is equally useful, because your prescriber can then plan a slower pace within the licence rather than leaving you to guess.

05 · What you may notice

What you may notice on 2.5mg

On 2.5mg you are likely to notice mild effects and modest change, though experiences differ widely. The 2.5mg starting weeks are about adjustment: some people notice appetite change and early loss in week one, others feel little until a higher dose, and both are normal.¹

Early loss includes water weight, so the trend over weeks matters more than any single weigh-in. If the scales dip in the first days and then stall, that is not a verdict on the treatment. Equally, if nothing moves at first, that does not mean the medicine will not work for you later on.

Side effects tend to be at their gentlest here. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹ This is the main reason some people want to stay low: they feel comfortable and are wary of feeling worse after an increase.

That caution is understandable, but it is worth weighing honestly. Comfortable can also mean the medicine is doing relatively little. Gentler side effects and gentler results often travel together, and the aim of a prescriber-led plan is to find a point where you gain meaningful benefit with side effects you can live with.

Appetite and fullness

You may feel less hungry between meals, or you may not. That is a common reason people ask whether the dose is working. If it is not noticeably changing your eating, say so at your review, because it is exactly the information used to decide the next step.

Pace of results

Weight loss on Mounjaro is gradual by design. Trials measured results at 72 weeks, so think in months, not days, and judge progress by trend, not individual weigh-ins.¹² If you are keeping a record, a weekly note of weight, appetite and side effects is more useful to your prescriber than a daily weigh-in. The GLPTrackr companion app is free and can help you keep that record.

Remember the other half of the picture too. Mounjaro is used alongside a reduced-calorie diet and increased physical activity, so what you eat and how you move still shape the result at every dose.

06 · Why progress stalls

Why 2.5mg may not seem to work

If 2.5mg is not working for you, the most likely reason is simply that it is the adjustment dose and was never meant to carry the whole job. Most measurable progress builds from 5mg onward, so a flat patch on the starter strength is common rather than alarming.¹

There are several other ordinary explanations worth checking before you conclude anything. None of them needs a number to be useful, and your prescriber can help you work through them.

• Timing. You may be judging results too early. The treatment is gradual, and early readings are muddied by water weight.
• Routine. A missed or irregular injection day can blunt consistency. Aim for the same day each week.
• Diet and activity. The medicine supports a reduced-calorie diet and more activity; it does not replace them.
• Individual response. Some people respond slowly at first and only notice appetite change at higher strengths. Both patterns are normal.
• Technique and storage. A pen kept badly, or one that was frozen, should not be used. Check storage before assuming the dose is the problem.

On storage: keep pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge not above 30°C for up to 30 days, after which it should be discarded.¹ If you are curious about freezing, our guide on what happens if you freeze Mounjaro covers it.

What not to do is chase a result by changing your own dosing. Changing your own dosing is not licensed and is unsafe. The right response to a stall is a conversation, not an experiment.

A plateau versus a slow start

A plateau means loss that had been happening has stopped; a slow start means it never really began. They have different causes and different answers. A plateau on a low dose after early loss is often a sign your body has adapted to that level, and a dose review is the natural next step. A slow start may simply need more time on a pathway that is still in its adjustment phase.

Either way, bring your notes to your review. The more clearly you can describe appetite, side effects, routine and weight trend, the easier it is for your prescriber to say whether holding, adjusting or stepping up fits you.

Many people also feel discouraged after seeing others report quick change at the start. Individual starts differ widely, and comparing yourself to someone else's week-one experience tells you very little about your own course. Judge yourself against your own trend over months, and against how you feel, not against anyone else's story.

07 · Stepping up safely

When and how to step up

You step up when your prescriber judges that you have settled on the current dose and a higher one is appropriate. The licence allows the first increase after at least 4 weeks, to 5mg, and further increases at a minimum of 4-week intervals.¹¹¹ Those are minimum gaps, not required ones, so a slower pace is entirely permitted where it suits you.

Reviews matter because the plan is meant to be responsive. Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ Note the phrase highest tolerated dose: the review assumes you have been allowed to move up to what suits you, not that you stayed on the starter strength throughout.

If your reluctance to increase is about side effects, say so. Your prescriber can hold a dose longer or step down within the licence if side effects are the concern.¹ That is a safe, supervised way to go slower, and it is very different from improvising your own schedule.

Practical points for the step up

• Order your next strength only after a review, so the pen matches the plan agreed.
• Keep to the same injection day each week, and rotate the site with each dose.
• Expect mild nausea, altered appetite or tiredness in the first days after an increase, as with the early weeks.
• Tell your prescriber if side effects feel more than mild.

If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day — never take two doses within 3 days of each other.¹ You can change your weekly injection day if needed, as long as at least 3 days (72 hours) have passed since your last dose.¹

If you are considering a longer hold on the starter strength, our related guides on whether you can stay on 2.5 mg long term and stay on it for three months look at those scenarios in more detail.

Finally, remember that stepping up is not a failure of the lower dose or a sign you are being rushed. It is the standard route the medicine was designed around, and your prescriber will pace it to how you actually feel.

08 · 2.5mg versus 5mg

2.5mg versus 5mg: what changes

The main difference is purpose: 2.5mg prepares your body, while 5mg is where most people begin to see measurable progress.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone. These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

Notice what that says about the starter dose: the figures are given for the working strengths, and the 2.5mg stage is described as an adjustment phase. That tells you where to expect the benefit to come from.

How to read trial averages

Trial averages do not predict your own result. Some people lose more, some less, and the pace varies. Use them as a sense of the range of what the licensed doses can do, not as a target or a promise. They also describe what happened over many months, which is why we encourage thinking in months rather than weeks.

A worked example makes the scale concrete without implying certainty. For someone starting at 100 kg, 20.9% is about 21 kg, which is the SURMOUNT-1 trial average on the highest dose over 72 weeks. It says nothing about what any one person will achieve on any one dose.

If you want to read more on the risk of stalling at the low end, see our guide on whether you can stay on 2.5 mg for weight loss.

09 · Stopping and clearance

What if you stop instead of stepping up

If you decide to stop rather than increase, the medicine clears slowly and nothing needs doing while it does. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system, and there is no way to speed this up.¹

That slow clearance has two practical consequences. First, any side effects you have are likely to fade gradually rather than overnight. Second, appetite effects may linger for a while and then change, so it is sensible to think ahead about eating habits rather than waiting to see what happens.

Stopping is a legitimate choice, and it is part of the review conversation. If a prescriber reviews your response and the outcome is modest, they will discuss whether continuing or stopping is right for you. Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load. What we would discourage is drifting: staying on a dose that is not helping, month after month, without a clear plan.

Questions to settle before you decide

• Do I want to try a higher strength, with a slower pace if needed?
• Are side effects the main barrier, and can my prescriber help with them?
• Am I following a reduced-calorie diet and being more active alongside treatment?
• Would a planned pause or stop suit my circumstances better?

Whatever you choose, tell your prescriber. They can help you plan around your goals and health, and they can reassess suitability at each repeat order, because repeat orders re-check suitability and there is no auto-shipping.

Other medicines and conditions

If you take other medicines, mention them at review, because some may need adjusting as treatment changes. Insulin and sulfonylureas, for example, may need dose adjustments because of the risk of low blood sugar. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase. This applies to the pill only — implants, coils and injections are unaffected.⁷

None of this changes just because you are on a low dose, and it is worth raising any change in your circumstances. If you feel unwell in a way you did not expect, tell your prescriber; for serious symptoms such as severe, persistent stomach pain, get medical help straight away.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · Cost, NHS and ordering

Cost, NHS access and how ordering works

Staying on 2.5mg does not change the way pens are ordered, but it does change what you are paying for. The standard price of a 2.5mg pen is £169.99 and a 5mg pen is £218.99, checked 11 October 2026. A new customer gets £40 off their first order at any dose with code FIRST40, and every later order is £25 off the standard price, with an automatic discount applied (code DOSE25). You can check live prices on the Mounjaro pen page.

Your dose is a clinical decision, not a cost one. If a lower dose is giving you little benefit, the sensible step is a review with your prescriber of whether you are on the right dose for your response.

NHS or private?

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions). Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁴⁶

If you are already on treatment through the NHS, follow your clinic's plan on dose.

How ordering works

• Free online consultation. A short health questionnaire, with no charge and no obligation.
• Prescriber review. Reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Dispensing and delivery. Dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm, then free next-day tracked delivery in temperature-controlled packaging. Saturday delivery is £14.99.

We supply genuine KwikPens through official LillyDirect supply, and all six strengths are in stock. We are a GPhC-registered pharmacy, registration 9012878, which you can verify on the GPhC register. The consultation is free, the price shown is the price paid, and payment options include Visa, Mastercard, Klarna and pay-monthly options, with no subscriptions.

Be wary of anyone offering to supply without a consultation or prescription, since counterfeit medicines are a real risk, and the MHRA publishes alerts on them.⁷

Needles, a sharps bin and injection guidance come with every order, and our support team is available Monday to Friday, 9am to 5pm, by email, account chat or phone on 0333 207 0413.